Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10745073 | 0.80 | ALDH1A1 (0.32) | MEN1LMNATP53GAAMAPT | |
| SCHEMBL9986042 | 0.77 | ALOX15 (0.43) | MEN1LMNATP53GAAMAPT | |
| SCHEMBL9986069 | 0.76 | MEN1 (0.36) | MEN1LMNATP53GAAMAPT | |
| SCHEMBL10883568 | 0.72 | ALDH1A1 (0.39) | MEN1LMNAGAAMAPTHPGD | |
| SCHEMBL199801 | 0.72 | GABRA1 (0.42) | MEN1LMNATP53MAPTHPGD | |
| SCHEMBL9985365 | 0.72 | MEN1 (0.33) | MEN1LMNATP53GAAMAPT | |
| SCHEMBL9810705 | 0.70 | ALOX15 (0.38) | MEN1LMNATP53GAAMAPT | |
| SCHEMBL1507773 | 0.70 | TRPA1 (0.36) | MEN1LMNATP53GAAMAPT | |
| SCHEMBL16431900 | 0.70 | MEN1 (0.37) | MEN1LMNATP53GAAMAPT | |
| SCHEMBL18378891 | 0.69 | ALDH1A1 (0.34) | MEN1LMNATP53MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3130635-B1 | RESIN COMPOSITION, CROSS-LINKED PRODUCT, AND METHOD FOR MANUFACTURING CROSS-LINKED PRODUCT | SUMITOMO CHEMICAL CO (JP) | 2020-02-26 | — | — | EP | disclosed |
| US-9909002-B2 | Resin composition, cross-linked product, and method for manufacturing cross-linked product | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-03-06 | — | — | US | disclosed |
| US-9695260-B2 | Method for producing olefin block polymer using plurality of types of transition metal catalysts | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-07-04 | — | — | US | disclosed |
| US-20170121516-A1 | RESIN COMPOSITION, CROSS-LINKED PRODUCT, AND METHOD FOR MANUFACTURING CROSS-LINKED PRODUCT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-05-04 | — | — | US | disclosed |
| US-9593194-B2 | Method for producing olefin block polymer using group 4 transition metal complex | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-03-14 | — | — | US | disclosed |
| EP-3130635-A1 | RESIN COMPOSITION, CROSS-LINKED PRODUCT, AND METHOD FOR MANUFACTURING CROSS-LINKED PRODUCT | Sumitomo Chemical Company Limited (JP) | 2017-02-15 | — | — | EP | disclosed |
| US-20140275429-A1 | METHOD FOR PRODUCING OLEFIN BLOCK POLYMER USING PLURALITY OF TYPES OF TRANSITION METAL CATALYSTS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-09-18 | — | — | US | disclosed |
| US-20140163173-A1 | METHOD FOR PRODUCING OLEFIN BLOCK POLYMER USING GROUP 4 TRANSITION METAL COMPLEX | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-06-12 | — | — | US | disclosed |
| US-8383848-B2 | Transition metal compound and catalyst for olefin polymerization | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-02-26 | — | — | US | disclosed |
| US-20130041119-A1 | OLEFIN POLYMER PRODUCING METHOD, ETHYLENE POLYMER, AND MOLD PRODUCT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-02-14 | — | — | US | disclosed |
| US-20110319578-A1 | TRANSITION METAL COMPOUND AND CATALYST FOR OLEFIN POLYMERIZATION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110319578-A1 | TRANSITION METAL COMPOUND AND CATALYST FOR OLEFIN POLYMERIZATION | AP1M1, SOD1, YAP1 | MEN1 759/4885LMNA 4321/4885TP53 4094/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.